GR1008112B - Pharmaceutical composition containing a selective serotonin receptor agonist and method for the preparation thereof - Google Patents

Pharmaceutical composition containing a selective serotonin receptor agonist and method for the preparation thereof

Info

Publication number
GR1008112B
GR1008112B GR20130100006A GR20130100006A GR1008112B GR 1008112 B GR1008112 B GR 1008112B GR 20130100006 A GR20130100006 A GR 20130100006A GR 20130100006 A GR20130100006 A GR 20130100006A GR 1008112 B GR1008112 B GR 1008112B
Authority
GR
Greece
Prior art keywords
preparation
pharmaceutical composition
receptor agonist
serotonin receptor
selective serotonin
Prior art date
Application number
GR20130100006A
Other languages
Greek (el)
Inventor
Ευαγγελος Ανδρεα Καραβας
Original Assignee
Φαρματεν Α.Β.Ε.Ε.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Φαρματεν Α.Β.Ε.Ε., filed Critical Φαρματεν Α.Β.Ε.Ε.,
Priority to GR20130100006A priority Critical patent/GR1008112B/en
Publication of GR1008112B publication Critical patent/GR1008112B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin

Abstract

The present invention relates to an improved pharmaceutical formulation of solid dosage forms for oral administration comprising a therapeutically effective amount of a selective serotonin receptor agonist or a pharmaceutically acceptable salt, derivative or polymorph thereof, in particular Rizatriptan, in combination with microcrystalline cellulose and starch maize in order to obtain a stable pharmaceutical composition. It also relates to a process for the preparation thereof.
GR20130100006A 2013-01-03 2013-01-03 Pharmaceutical composition containing a selective serotonin receptor agonist and method for the preparation thereof GR1008112B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GR20130100006A GR1008112B (en) 2013-01-03 2013-01-03 Pharmaceutical composition containing a selective serotonin receptor agonist and method for the preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20130100006A GR1008112B (en) 2013-01-03 2013-01-03 Pharmaceutical composition containing a selective serotonin receptor agonist and method for the preparation thereof

Publications (1)

Publication Number Publication Date
GR1008112B true GR1008112B (en) 2014-02-11

Family

ID=50389732

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20130100006A GR1008112B (en) 2013-01-03 2013-01-03 Pharmaceutical composition containing a selective serotonin receptor agonist and method for the preparation thereof

Country Status (1)

Country Link
GR (1) GR1008112B (en)

Similar Documents

Publication Publication Date Title
PH12015500460A1 (en) Coated pharmaceutical composition containing regorafenib
WO2013188273A8 (en) Topical ophthalmological pharmaceutical composition containing axitinib
TN2013000533A1 (en) Topical ophthalmological pharmaceutical composition containing regorafenib
WO2013188268A8 (en) Topical ophthalmological pharmaceutical composition containing pazopanib
MX2016009621A (en) Furo-3-carboxamide derivatives and methods of use.
MX2016005030A (en) Fused benzazepines for treatment of stuttering.
UA107702C2 (en) Novel benzamide derivatives
TN2015000280A1 (en) Topical Ophthalmological Pharmaceutical Composition containing Regorafenib
GR1008228B (en) Pharmaceutical composition comprising a dual reuptake inhibitor and method for the preparation thereof
GR1008112B (en) Pharmaceutical composition containing a selective serotonin receptor agonist and method for the preparation thereof
JOP20200127A1 (en) Pyridinone derivatives and their use as selective alk-2 inhibitors
NZ712369A (en) 5-amino-quinoline-8-carboxamide derivatives as 5-ht4 receptor agonists
GR1008821B (en) Pharmaceutical composition comprising ivabradine hydrochloride and method for preparation thereof
GR1007712B (en) Pharmaceutical composition containing leukotriene receptor antagonist and method for the preparation thereof
GR1008819B (en) Pharmaceutical composition comprising atomoxetine and method for the preparation thereof
GR1008169B (en) Pharmaceutical composition comprising a fluoroquinolone antibacterial agent and method for the preparation thereof
PE20151430A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DEXKETOPROFEN AND TRAMADOL
GR1007741B (en) Pharmaceutical composition containing an atypical antipsychotic agent and method for the preparation thereof
GR1008380B (en) Pharmaceutical composition comprising an antiviral agent and method for the preparation thereof
GR1007629B (en) Controlled-release pharmaceutical formulation of a non-ergoline dopamine agonist
PH12016502540A1 (en) Pharmaceutical dosage forms
WO2014141298A3 (en) Stable pharmaceutical composition of fingolimod
IN2013MU02366A (en)
WO2016193456A3 (en) Opioid receptor antagonist for use in treating patients with severe constipation
GR1007754B (en) PHARMACEUTICAL CONSTRUCTION CONTAINING AN OUTCOMES OF ESTROGONE RECEPTORS AND A METHOD FOR PREPARING IT

Legal Events

Date Code Title Description
PG Patent granted

Effective date: 20140317